Likewise, Maktabi et al. [33] observed a significant decrease in fasting plasma glucose, HOMA-IR, homeostasis model assessment-estimated beta cell function (HOMA-β), CRP, and plasma malondialdehyde in 70 PCOS women receiving 50,000 IU of cholecalciferol every 14 days vs. placebo over 12 weeks. Here, CRP is linked to polycystic ovary syndrome.